Frontiers in Medicine (Nov 2021)
Increased INR Values Predict Accelerating Deterioration and High Short-Term Mortality Among Patients Hospitalized With Cirrhosis or Advanced Fibrosis
- Ying Wang,
- Ying Wang,
- Fuchen Dong,
- Fuchen Dong,
- Shuning Sun,
- Shuning Sun,
- Xianbo Wang,
- Xianbo Wang,
- Xin Zheng,
- Xin Zheng,
- Yan Huang,
- Yan Huang,
- Beiling Li,
- Beiling Li,
- Yanhang Gao,
- Yanhang Gao,
- Zhiping Qian,
- Zhiping Qian,
- Feng Liu,
- Feng Liu,
- Xiaobo Lu,
- Xiaobo Lu,
- Junping Liu,
- Junping Liu,
- Haotang Ren,
- Haotang Ren,
- Yubao Zheng,
- Yubao Zheng,
- Huadong Yan,
- Huadong Yan,
- Guohong Deng,
- Guohong Deng,
- Liang Qiao,
- Liang Qiao,
- Yan Zhang,
- Yan Zhang,
- Wenyi Gu,
- Wenyi Gu,
- Xiaomei Xiang,
- Xiaomei Xiang,
- Yi Zhou,
- Yi Zhou,
- Baoyan Xu,
- Baoyan Xu,
- Yixin Hou,
- Yixin Hou,
- Qun Zhang,
- Qun Zhang,
- Yan Xiong,
- Yan Xiong,
- Congcong Zou,
- Congcong Zou,
- Jun Chen,
- Jun Chen,
- Zebing Huang,
- Zebing Huang,
- Xiuhua Jiang,
- Xiuhua Jiang,
- Tingting Qi,
- Tingting Qi,
- Sen Luo,
- Sen Luo,
- Yuanyuan Chen,
- Yuanyuan Chen,
- Na Gao,
- Na Gao,
- Chunyan Liu,
- Chunyan Liu,
- Wei Yuan,
- Wei Yuan,
- Xue Mei,
- Xue Mei,
- Jing Li,
- Jing Li,
- Tao Li,
- Tao Li,
- Rongjiong Zheng,
- Rongjiong Zheng,
- Xinyi Zhou,
- Xinyi Zhou,
- Weituo Zhang,
- Weituo Zhang,
- Hai Li,
- Hai Li,
- Zhongji Meng,
- Zhongji Meng
Affiliations
- Ying Wang
- Department of Infectious Disease, Hubei Clinical Research Center for Precise Diagnosis and Treatment of Liver Cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China
- Ying Wang
- Chinese Chronic Liver Failure Consortium, China
- Fuchen Dong
- Chinese Chronic Liver Failure Consortium, China
- Fuchen Dong
- Department of Gastroenterology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China
- Shuning Sun
- Chinese Chronic Liver Failure Consortium, China
- Shuning Sun
- Department of Infectious Diseases, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China
- Xianbo Wang
- Chinese Chronic Liver Failure Consortium, China
- Xianbo Wang
- Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China
- Xin Zheng
- Chinese Chronic Liver Failure Consortium, China
- Xin Zheng
- Department of Infectious Diseases, Tongji Medical College, Institute of Infection and Immunology, Union Hospital, Huazhong University of Science and Technology, Wuhan, China
- Yan Huang
- Chinese Chronic Liver Failure Consortium, China
- Yan Huang
- Hunan Key Laboratory of Viral Hepatitis, Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha, China
- Beiling Li
- Chinese Chronic Liver Failure Consortium, China
- Beiling Li
- Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Yanhang Gao
- Chinese Chronic Liver Failure Consortium, China
- Yanhang Gao
- Department of Hepatology, The First Hospital of Jilin University, Jilin, China
- Zhiping Qian
- Chinese Chronic Liver Failure Consortium, China
- Zhiping Qian
- 0Department of Liver Intensive Care Unit, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, China
- Feng Liu
- Chinese Chronic Liver Failure Consortium, China
- Feng Liu
- 1Department of Infectious Diseases and Hepatology, The Second Hospital of Shandong University, Jinan, China
- Xiaobo Lu
- Chinese Chronic Liver Failure Consortium, China
- Xiaobo Lu
- 2Infectious Disease Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
- Junping Liu
- Chinese Chronic Liver Failure Consortium, China
- Junping Liu
- 3Department of Infectious Diseases, Henan Provincial People's Hospital, Henan, China
- Haotang Ren
- Chinese Chronic Liver Failure Consortium, China
- Haotang Ren
- 4State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
- Yubao Zheng
- Chinese Chronic Liver Failure Consortium, China
- Yubao Zheng
- 5Department of Infectious Diseases, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
- Huadong Yan
- Chinese Chronic Liver Failure Consortium, China
- Huadong Yan
- 6Department of Infectious Diseases, Hwamei Hospital, Ningbo No. 2 Hospital, University of Chinese Academy of Sciences, Ningbo, China
- Guohong Deng
- Chinese Chronic Liver Failure Consortium, China
- Guohong Deng
- Department of Infectious Diseases, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China
- Liang Qiao
- Chinese Chronic Liver Failure Consortium, China
- Liang Qiao
- Department of Gastroenterology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China
- Yan Zhang
- Chinese Chronic Liver Failure Consortium, China
- Yan Zhang
- Department of Gastroenterology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China
- Wenyi Gu
- Chinese Chronic Liver Failure Consortium, China
- Wenyi Gu
- Department of Gastroenterology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China
- Xiaomei Xiang
- Chinese Chronic Liver Failure Consortium, China
- Xiaomei Xiang
- Department of Infectious Diseases, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China
- Yi Zhou
- Chinese Chronic Liver Failure Consortium, China
- Yi Zhou
- Department of Infectious Diseases, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China
- Baoyan Xu
- Chinese Chronic Liver Failure Consortium, China
- Baoyan Xu
- Department of Infectious Diseases, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China
- Yixin Hou
- Chinese Chronic Liver Failure Consortium, China
- Yixin Hou
- Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China
- Qun Zhang
- Chinese Chronic Liver Failure Consortium, China
- Qun Zhang
- Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China
- Yan Xiong
- Chinese Chronic Liver Failure Consortium, China
- Yan Xiong
- Department of Infectious Diseases, Tongji Medical College, Institute of Infection and Immunology, Union Hospital, Huazhong University of Science and Technology, Wuhan, China
- Congcong Zou
- Chinese Chronic Liver Failure Consortium, China
- Congcong Zou
- Department of Infectious Diseases, Tongji Medical College, Institute of Infection and Immunology, Union Hospital, Huazhong University of Science and Technology, Wuhan, China
- Jun Chen
- Chinese Chronic Liver Failure Consortium, China
- Jun Chen
- Hunan Key Laboratory of Viral Hepatitis, Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha, China
- Zebing Huang
- Chinese Chronic Liver Failure Consortium, China
- Zebing Huang
- Hunan Key Laboratory of Viral Hepatitis, Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha, China
- Xiuhua Jiang
- Chinese Chronic Liver Failure Consortium, China
- Xiuhua Jiang
- Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Tingting Qi
- Chinese Chronic Liver Failure Consortium, China
- Tingting Qi
- Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Sen Luo
- Department of Infectious Disease, Hubei Clinical Research Center for Precise Diagnosis and Treatment of Liver Cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China
- Sen Luo
- Chinese Chronic Liver Failure Consortium, China
- Yuanyuan Chen
- Department of Infectious Disease, Hubei Clinical Research Center for Precise Diagnosis and Treatment of Liver Cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China
- Yuanyuan Chen
- Chinese Chronic Liver Failure Consortium, China
- Na Gao
- Chinese Chronic Liver Failure Consortium, China
- Na Gao
- Department of Hepatology, The First Hospital of Jilin University, Jilin, China
- Chunyan Liu
- Chinese Chronic Liver Failure Consortium, China
- Chunyan Liu
- Department of Hepatology, The First Hospital of Jilin University, Jilin, China
- Wei Yuan
- Chinese Chronic Liver Failure Consortium, China
- Wei Yuan
- 0Department of Liver Intensive Care Unit, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, China
- Xue Mei
- Chinese Chronic Liver Failure Consortium, China
- Xue Mei
- 0Department of Liver Intensive Care Unit, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, China
- Jing Li
- Chinese Chronic Liver Failure Consortium, China
- Jing Li
- 1Department of Infectious Diseases and Hepatology, The Second Hospital of Shandong University, Jinan, China
- Tao Li
- Chinese Chronic Liver Failure Consortium, China
- Tao Li
- 1Department of Infectious Diseases and Hepatology, The Second Hospital of Shandong University, Jinan, China
- Rongjiong Zheng
- Chinese Chronic Liver Failure Consortium, China
- Rongjiong Zheng
- 2Infectious Disease Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
- Xinyi Zhou
- Chinese Chronic Liver Failure Consortium, China
- Xinyi Zhou
- 2Infectious Disease Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
- Weituo Zhang
- Chinese Chronic Liver Failure Consortium, China
- Weituo Zhang
- 7Clinical Research Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Hai Li
- Chinese Chronic Liver Failure Consortium, China
- Hai Li
- Department of Gastroenterology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China
- Zhongji Meng
- Department of Infectious Disease, Hubei Clinical Research Center for Precise Diagnosis and Treatment of Liver Cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China
- Zhongji Meng
- Chinese Chronic Liver Failure Consortium, China
- DOI
- https://doi.org/10.3389/fmed.2021.762291
- Journal volume & issue
-
Vol. 8
Abstract
Background and Objective: An increase in the international normalized ratio (INR) is associated with increased mortality in patients with cirrhosis and other chronic liver diseases, while little is known about the quantitative relationship. This study aimed to investigate the quantitative relationship between the INR and short-term prognosis among patients hospitalized with cirrhosis or advanced fibrosis and to evaluate the role of the INR as a risk factor for short-term liver transplant (LT)-free mortality in these patients.Patients and Methods: This study prospectively analyzed multicenter cohorts established by the Chinese Acute-on-Chronic Liver Failure (CATCH-LIFE) study. Cox regression was used to describe the relationship between the INR and independent risk factors for short-term LT-free mortality. Forest plots were used in the subgroup analysis. Generalized additive models (GAMs) and splines were used to illustrate the quantitative curve relationship between the INR and the outcome and inflection point on the curve.Results: A total of 2,567 patients with cirrhosis and 924 patients with advanced fibrosis were included in the study. The 90-day LT-free mortality of patients with cirrhosis and advanced fibrosis was 16.7% (428/2,567) and 7.5% (69/924), respectively. In the multivariable Cox regression analysis, the increase in the INR was independently associated with the risk of 90-day LT-free mortality both in patients with cirrhosis (HR, 1.06; 95% CI, 1.04–1.07, p < 0.001) and in patients with advanced fibrosis (HR, 1.09; 95% CI, 1.06–1.12, p < 0.001). An INR of 1.6/1.7 was found to be the starting point of coagulation dysfunction with a rapid increase in mortality in patients with cirrhosis or in patients with advanced fibrosis, respectively. A 28-day LT-free mortality of 15% was associated with an INR value of 2.1 in both cirrhosis and advanced fibrosis patients.Conclusions: This study was the first to quantitatively describe the relationship between the INR and short-term LT-free mortality in patients with cirrhosis or advanced fibrosis. The starting points of INR indicating the rapid increase in mortality and the unified cutoff value of coagulation failure in cirrhosis and advanced fibrosis, will help clinicians accurately recognize early disease deterioration.
Keywords
- acute on chronic liver failure (ACLF)
- cirrhosis
- advanced fibrosis
- international normalized ratio (INR)
- short-term prognosis